SCHEMBL12759585

SCHEMBL12759585

CC(C)(C)Cc1ccc2c(c1)c1ccccc1c1nc(CCC3CC(CCc4cn5c6ccc(CC(C)(C)C)cc6c6ccccc6c5n4)CC(CCc4cn5c6ccc(CC(C)(C)C)cc6c6ccccc6c5n4)C3)cn21

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RORA P35398 2/20 0.32
RORC P51449 2/20 0.32
RORB Q92753 2/20 0.32
PGR P06401 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL861778 0.79 PTAFR (0.38) RORARORCRORBPGR
SCHEMBL861337 0.74 PGR (0.40) RORARORCRORBPGR
SCHEMBL861753 0.67 KDM4E (0.37) RORARORCRORBPGR
SCHEMBL29929754 0.64 ADORA2A (0.35)
SCHEMBL9968160 0.63 GPR3 (0.53) RORARORCRORBPGR
SCHEMBL12759590 0.63 MAPT (0.39) RORARORCRORBPGR
SCHEMBL861579 0.62 PGR (0.33) RORARORCRORBPGR
SCHEMBL25725654 0.62 MAPT (0.41) RORARORCRORBPGR
SCHEMBL25882845 0.62 MAPT (0.41) RORARORCRORBPGR
SCHEMBL12145786 0.62 ATM (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device UDC IRELAND LTD (IE) 2015-10-29 US disclosed
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device UDC IRELAND LTD (IE) 2015-10-29 US disclosed
US-9062084-B2 Method of forming metal complex compound, and organic electroluminescence device UDC Ireland (IE) 2015-06-23 US disclosed
US-9062084-B2 Method of forming metal complex compound, and organic electroluminescence device UDC Ireland (IE) 2015-06-23 US disclosed
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE ZFR, PORCN, OR10J3 RORA 2945/4885RORC 2265/4885RORB 3476/4885
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device ZFR, PORCN, OR10J3 RORA 2945/4885RORC 2265/4885RORB 3476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.